Journal of Pediatric Neurology 2011; 09(04): 465-468
DOI: 10.3233/JPN-2012-0514
Georg Thieme Verlag KG Stuttgart – New York

Dexmedetomidine for sedation following cerebral angiography

Thomas Taghon
a   Department of Anesthesiology, Nationwide Children's Hospital and the Ohio State University, Columbus, OH, USA
,
Andrew J. Rabe
b   Department of Radiology, Nationwide Children's Hospital and the Ohio State University Columbus, OH, USA
,
Joseph D. Tobias
c   Departments of Anesthesiology and Pediatrics, Nationwide Children's Hospital and the Ohio State University, Columbus, OH, USA
› Author Affiliations

Subject Editor:
Further Information

Publication History

21 January 2011

08 March 2011

Publication Date:
30 July 2015 (online)

Abstract

Dexmedetomidine, a centrally acting α2-adrenergic agonist, is being used with increased frequency in the pediatric population due to its unique ability to render patients in a sedated, yet cooperative state, with a limited risk of adverse respiratory or hemodynamic effects. We report the successful use of dexmedetomidine to provide sedation following general anesthesia in two adolescents following cerebral angiography. Dexmedetomidine was used with limited effects on hemodynamic and ventilatory function to provide sedation and limit movement to prevent hematoma formation at the femoral artery cannulation site. Both patients had underlying neurobehavioral disorders, which precluded their ability to cooperate with a prolonged period of post-procedure immobility. The potential application of dexmedetomidine in this unique patient population is discussed.